Articles from Owlet, Inc.

Owlet, Inc. (“Owlet” or the “Company”) (NYSEOWLT), the pioneer of smart infant monitoring, today announces the launch of Owlet360™, a new subscription service available to Owlet customers. This innovative new service leverages the Company’s infant health and sleep data to provide caregivers a place to turn to for answers about their babies’ development and health, empowering them with actionable information – while ensuring Owlet’s core safety features, including live vitals monitoring and real-time alerts, remain free of charge.

Owlet, Inc. (“Owlet” or the “Company”) (NYSEOWLT), the pioneer of smart infant monitoring, today reports financial results for the third quarter ended September 30, 2024. Owlet’s Chief Executive Officer and Co-Founder, Kurt Workman, President and Chief Revenue Officer, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company’s results and provide a business update today, November 13, 2024, at 4:30 p.m. ET.

Owlet, Inc. (“Owlet” or the “Company”) (NYSEOWLT), the pioneer of smart infant monitoring, announced today the participation in two upcoming investor conferences. Information on the conferences can be found below.

Owlet, Inc. (“Owlet” or the “Company”) (NYSEOWLT), the pioneer of smart infant monitoring, plans to announce third quarter 2024 financial results after market close on Wednesday, November 13, 2024. Owlet’s Chief Executive Officer and Co-Founder, Kurt Workman, President and Chief Revenue Officer, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call at 4:30 p.m. ET the same day to discuss these results and provide a business update.

Owlet, Inc. (“Owlet” or the “Company”) (NYSEOWLT), a pioneer of smart infant monitoring, today announced that it has received formal notice from the New York Stock Exchange (“NYSE”) that the Company has regained compliance with the NYSE’s continued listing standards.

Owlet, Inc. (“Owlet” or the “Company”) (NYSEOWLT), the pioneer of smart infant monitoring, today released its State of Parenting Report, which reveals the immense pressure parents face during their baby’s first year of life. On average, parents lose three hours of sleep per night,1 contributing to higher levels of stress and fatigue. With 126 million pediatric visits every year,2 it’s clear that health concerns also weigh heavily on parents’ minds. The number one reason for these visits is respiratory infections,3 and parents remain deeply concerned about sudden and unexpected health issues. Still today, one of the leading causes of infant mortality is unexpected deaths during sleep, caused by sudden infant death syndrome (SIDS), suffocation, and other unknown factors.4 The new data sheds even more light on these struggles, along with the common feelings that overwhelm new parents, as well as the tools they seek for support.

Owlet, Inc. (“Owlet” or the “Company”) (NYSEOWLT), the pioneer of smart infant monitoring, today announced the closing of its underwritten public offering of 3,135,136 shares of the Company’s Class A common stock (the “Offering”). The shares of Class A common stock were sold at a public offering price of $3.70 per share, before underwriting discounts and commissions. All of the shares in the Offering were sold by the Company. The gross proceeds to Owlet from the Offering were approximately $11.6 million, before deducting underwriting discounts and commissions and other offering expenses.

Owlet, Inc. (“Owlet” or the “Company”) (NYSEOWLT), the pioneer of smart infant monitoring, today announced the pricing of an underwritten public offering of 3,135,136 shares of the Company’s Class A common stock (the “Offering”). The shares of Class A common stock are being sold at a public offering price of $3.70 per share, before underwriting discounts and commissions. All of the shares in the Offering are to be sold by the Company. The gross proceeds to Owlet from the Offering are expected to be approximately $11.6 million, before deducting underwriting discounts and commissions and other offering expenses. The Offering is expected to close on or about September 13, 2024, subject to the satisfaction of customary closing conditions.

Owlet, Inc. (“Owlet” or the “Company”) (NYSEOWLT), the pioneer of smart infant monitoring, today announced it intends to offer and sell its Class A common stock in an underwritten public offering. In addition, the Company intends to grant the underwriter a 30-day option to purchase up to an additional 15% of the gross proceeds of its Class A common stock at the public offering price per share, before underwriting discounts and commissions. All of the shares in the proposed offering are to be sold by the Company.

Owlet, Inc. (“Owlet” or the “Company”) (NYSEOWLT), the pioneer of smart infant monitoring, announced today at Kind + Jugend in Cologne, Germany, that medically-certified Dream Sock will soon be available in even more countries, including Poland, Greece, and the Czech Republic. Dream Sock is the Company’s medically-certified baby monitor accessible across Europe, giving parents safe and accurate health readings and actionable alarms while their baby sleeps.

Owlet, Inc. (“Owlet” or the “Company”) (NYSEOWLT), the pioneer of smart infant monitoring, today reports financial results for the second quarter ended June 30, 2024. Owlet’s Chief Executive Officer and Co-Founder, Kurt Workman, President and Chief Revenue Officer, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company’s results and provide a business update today, August 12, 2024, at 4:30 p.m. ET.

Today, Owlet, Inc. (NYSEOWLT) (the “Company” or “Owlet”), the pioneer of smart infant monitoring, launched Only Owlet, a global campaign that brings together new research and real-life stories to spotlight the common anxieties parents all experience, and how Owlet helps empower families around the world by helping them through the most difficult of challenges.

Owlet, Inc. (“Owlet” or the “Company”) (NYSEOWLT), the pioneer of smart infant monitoring, today announced that Kate Scolnick, Chief Financial Officer (“CFO”), will be departing the Company to pursue other opportunities. Amanda Twede Crawford, Owlet’s Vice President, Financial Planning and Analysis, will assume the role of CFO. Kate will remain at the Company in an advisory role for a transition period through September 2024.

Owlet, Inc. (“Owlet” or the “Company”) (NYSEOWLT), the pioneer of smart infant monitoring, today announces the UK and European launch of Dream Sock, a smart baby monitor with live health readings and notifications for healthy infants between 0-18 months and 2.5-13.6 kg. This innovative medical device provides parents with real-time health and vital information, offering unparalleled peace of mind.

Owlet, Inc. (“Owlet” or the “Company”) (NYSEOWLT), the pioneer of smart infant monitoring, announced today its participation in the 8th Annual Cowen Future of the Consumer Conference, being held in New York City on June 4-5, 2024.

Owlet, Inc. (“Owlet” or the “Company”) (NYSEOWLT), the pioneer of smart infant monitoring, has received UK medical device certification, following the recent achievement of CE Mark certification. This marks a significant milestone for Owlet, moving the company forward in its mission to increase access to medical-grade infant monitoring technology to parents and caregivers around the world.

Owlet, Inc. (“Owlet” or the “Company”) (NYSEOWLT), the pioneer of smart infant monitoring, today reports financial results for the first quarter ended March 31, 2024. Owlet’s Chief Executive Officer and Co-Founder, Kurt Workman, President and Chief Revenue Officer, Jonathan Harris, and Chief Financial Officer, Kate Scolnick, will host a conference call to review the Company’s results and provide a business update today, May 6, 2024, at 4:30 p.m. ET.

Owlet, Inc. (“Owlet” or the “Company”) (NYSEOWLT), the pioneer of smart infant monitoring, announces the EU medical device certification of Dream Sock. This EU-CE-Mark certification, issued by Owlet’s EU notified body, signifies that Owlet’s Dream Sock has been assessed and certified to meet safety and health requirements set out under EU medical device legislation. With this certification, Owlet plans to expand its medical-device product portfolio to even more caregivers around the world.

Owlet, Inc. (“Owlet” or the “Company”) (NYSEOWLT), the pioneer of smart infant monitoring, announced today the participation in two upcoming investor conferences. Information on the conferences can be found below.

Owlet, Inc. (“Owlet” or the “Company”) (NYSEOWLT), the pioneer of smart infant monitoring, will release its first quarter 2024 financial results after the market closes on May 6, 2024. Owlet will issue a copy of the earnings release via Business Wire and include a copy on Owlet’s Investor Relations website at investors.owletcare.com. Owlet’s Chief Executive Officer, Kurt Workman, President and Chief Revenue Officer, Jonathan Harris, and Chief Financial Officer, Kate Scolnick, will host a conference call that same day at 4:30 p.m. ET to discuss these results and provide a business update.

Owlet, Inc. (“Owlet” or the “Company”) (NYSEOWLT), the pioneer of smart infant monitoring, announces a strategic partnership with Wheel, an industry leader in providing virtual patient-centric care. Through this partnership, Wheel clinicians will provide caregivers of infants with timely prescriptions for BabySat™, Owlet’s FDA-cleared infant pulse oximeter, ushering in a new era of digital healthcare solutions for families.

Owlet, Inc. (“Owlet” or the “Company”) (NYSEOWLT), the pioneer of smart infant monitoring, today reported financial results for the fourth quarter and fiscal year ended December 31, 2023. Owlet’s Chief Executive Officer and Co-Founder, Kurt Workman, and Chief Financial Officer, Kate Scolnick, will host a conference call to review the Company’s results and provide a business update today, March 7, 2024, at 4:30 p.m. ET.

Owlet, Inc. (NYSEOWLT) (“Owlet” or the “Company”) announced today, following recent FDA clearances and strong preliminary fourth quarter results, that it has entered into definitive documentation relating to a sale of shares of its newly issued Series B convertible preferred stock (“Series B preferred stock”) and warrants to purchase its Class A common stock (“common stock”) in a private placement with certain institutional and other accredited investors for gross proceeds to Owlet of approximately $9 million, before deducting offering expenses. The conversion ratio for the Series B preferred stock and exercise price for the warrants reflects a 25% premium to the most recent market closing price on February 23, 2024. The transaction, which involves participation from existing investors, is expected to close on February 28, 2024, subject to customary closing conditions.

Owlet, Inc. (“Owlet”) (NYSEOWLT), the pioneer of smart infant monitoring, today announced that it will participate in the 44th Annual Cowen Health Care Conference, taking place on March 4 – March 6, 2024 at the Marriott Copley Place in Boston, Massachusetts. Kurt Workman, Owlet’s Co-Founder and Chief Executive Officer, and Kate Scolnick, Chief Financial Officer, are scheduled to engage in a fireside chat on Tuesday, March 5, 2024, at 2:50 p.m. Eastern Time.

Owlet, Inc. (“Owlet” or the “Company”) (NYSEOWLT), the pioneer of smart infant monitoring, today announces the following preliminary unaudited results for the fourth quarter 2023.

Owlet, Inc. (“Owlet” or the “Company”) (NYSEOWLT), the pioneer of smart infant monitoring, today announces the launch and availability of Dream Sock® and BabySat™, two medical devices with recent clearances from the U.S. Food and Drug Administration (“FDA”). Both innovations deliver real-time health insights with medical-grade accuracy and unprecedented advancements for at-home infant care.

Owlet, Inc. (“Owlet”) (NYSEOWLT) today announced that it will participate in the BTIG Digital Health Forum, taking place on Monday, November 20, 2023, virtually. Kurt Workman, Owlet’s Co-Founder and Chief Executive Officer, and Kate Scolnick, Chief Financial Officer, are scheduled to engage in a fireside chat on Monday, November 20, at 11 a.m. Eastern Time. Management will also participate in 1x1 meetings which may be requested through BTIG.

Owlet, Inc. (“Owlet” or the “Company”) (NYSEOWLT) today reported financial results for the third quarter ended September 30, 2023. Owlet’s Chief Executive Officer, Kurt Workman, and Chief Financial Officer, Kate Scolnick, will host a conference call to review the Company’s results and provide a business update today, November 13, 2023, at 4:30 p.m. ET.

Owlet, Inc. (NYSEOWLT) (the “Company” or “Owlet”), the pioneer of smart infant monitoring, announces De Novo clearance from the U.S. Food and Drug Administration (“FDA”) of Dream Sock, the first and only over-the-counter medical pulse oximetry solution for infants. Owlet is spearheading new standards for consumer and medical solutions, allowing caregivers to provide better care at home for their babies through access to advanced digital health technologies.

Owlet, Inc. (“Owlet”) (NYSEOWLT) will release its third quarter 2023 results after the market closes on November 13, 2023. Owlet will issue a copy of the earnings release via Business Wire and include a copy on Owlet’s Investor Relations website at investors.owletcare.com. Owlet’s Chief Executive Officer, Kurt Workman, and Chief Financial Officer, Kate Scolnick, will host a conference call that same day at 4:30 p.m. ET to discuss these results and provide a business update.

Owlet, Inc. (“Owlet” or the “Company”) (NYSEOWLT), a pioneer of smart baby monitoring, is on a mission to raise critical funds for research that could bring an end to sudden infant death syndrome (SIDS). Owlet is partnering in this effort with Dr. Carmel Harrington, Honorary Research Fellow at Sydney Children's Hospital Westmead, and Elisha Palmer of Knox Blocks Foundation, both of whom are parents that have lost a child to SIDS.

Owlet, Inc. (“Owlet” or the “Company”) (NYSEOWLT), a pioneer of smart baby monitoring, today announces the appointment of Marc Stoll to the Company’s Board of Directors. Stoll is currently an Investment Partner at Eclipse, a strategic investment firm focused on advancing the Industrial Evolution. His experience spans more than 25 years across the global finance and technology industries, and his expertise in leading corporate strategy and operational excellence will help bolster Owlet’s future ventures and growth potential.

Owlet, Inc. (“Owlet” or the “Company”) (NYSEOWLT) today reported financial results for the second quarter ended June 30, 2023. Owlet’s Chief Executive Officer, Kurt Workman, and Chief Financial Officer, Kate Scolnick, will host a conference call to review the Company’s results and provide a business update today, August 14, 2023, at 4:30 p.m. ET.

Owlet, Inc. (NYSEOWLT) will release its second quarter 2023 financial results after the market closes on August 14, 2023. Owlet will issue a copy of the earnings release via Business Wire and include a copy on Owlet’s Investor Relations website at investors.owletcare.com. Owlet’s Chief Executive Officer, Kurt Workman, and Chief Financial Officer, Kate Scolnick, will host a conference call that same day at 4:30 p.m. ET to discuss these results and provide a business update.

Owlet, Inc. (“Owlet” or the “Company”) (NYSEOWLT), a pioneer of smart baby monitoring, today announces the appointment of executive Jonathan Harris as its new President and Chief Revenue Officer. Harris joins Owlet at a pivotal time in its business – one month after receiving clearance from the U.S. Food and Drug Administration (“FDA”) of BabySat™, the first medical pulse-oximetry device featuring Owlet’s advanced, wire-free sock design.

Owlet, Inc. (NYSE: OWLT, “the Company”), the pioneer of smart baby monitoring, is pleased to announce the addition of Melissa Gonzales to the Company’s Board of Directors. Gonzales brings more than 20 years of consumer and provider healthcare experience to Owlet, further advancing the Company as a leader in infant monitoring solutions.

Owlet, Inc. (NYSEOWLT) (“Owlet” or the “Company”) today announced that the New York Stock Exchange (“NYSE”) has accepted the Company’s business plan to regain compliance with the continued listing standards set forth in Section 802.01B of the NYSE Listed Company Manual.

Owlet, Inc. (NYSEOWLT) (“Owlet” or the “Company”) today announced that the previously announced 1-for-14 reverse stock split (“Reverse Split”) of its Class A common stock, $0.0001 par value per share (“Common Stock”), will become effective at 5:00 p.m. EDT today, July 7, 2023. The shares of the Company’s Common Stock will begin trading on the New York Stock Exchange (“NYSE”) on a split-adjusted basis when markets open on Monday, July 10, 2023 under the existing trading symbol “OWLT” and new CUSIP number: 69120X206.

Owlet, Inc. (NYSEOWLT) (“Owlet” or the “Company”), today announced that its Board of Directors (the “Board”) has approved a 1-for-14 reverse stock split (“Reverse Split”) of its Class A common stock, $0.0001 par value per share (“Common Stock”), that is expected to become effective on July 7, 2023 at 5:00 p.m. EDT. The shares of the Company’s Common Stock are expected to begin trading on the New York Stock Exchange (“NYSE”) on a split-adjusted basis at the market open on July 10, 2023. No change will be made to the trading symbol for the Company’s shares of Common Stock, “OWLT” in connection with the Reverse Split.

Owlet, Inc. (“Owlet” or the “Company”) (NYSEOWLT) today reported financial results for the first quarter ended March 31, 2023. Owlet’s Chief Executive Officer and President, Kurt Workman, and Chief Financial Officer, Kate Scolnick, will host a conference call to review the Company’s results and provide a business update today, May 11, 2023, at 4:30 p.m. ET.

Owlet, Inc. (NYSEOWLT) will release its first quarter 2023 financial results after the market closes on May 11, 2023. Owlet will issue a copy of the earnings release via Business Wire and include a copy on Owlet’s Investor Relations website at investors.owletcare.com. Owlet’s President and Chief Executive Officer, Kurt Workman, and Chief Financial Officer, Kate Scolnick, will host a conference call that same day at 4:30 p.m. ET to discuss these results and provide a business update.

Owlet, Inc. (NYSEOWLT) (the “Company” or “Owlet”) reports that, on April 4, 2023, it received written notice (the “NYSE Notification”) from the New York Stock Exchange (“NYSE”) that the Company is not in compliance with Section 802.01B of the NYSE Listed Company Manual because its average global market capitalization over a consecutive 30 day trading day period was less than $50 million and, at the same time, its last reported stockholders’ equity was less than $50 million.

Owlet, Inc. (“Owlet” or the “Company”) (NYSEOWLT) today reported financial results for the fourth quarter and fiscal year ended December 31, 2022. Owlet’s Chief Executive Officer and President, Kurt Workman, and Chief Financial Officer, Kate Scolnick, will host a conference call to review the Company’s results and provide a business update today, March 15, 2023, at 4:30 p.m. ET.

Owlet, Inc. (NYSEOWLT) will release its fourth quarter 2022 financial results after the market closes on March 15, 2023. Owlet will issue a copy of the earnings release via Business Wire and include a copy on Owlet’s Investor Relations website at investors.owletcare.com. Owlet’s President and Chief Executive Officer, Kurt Workman, and Chief Financial Officer, Kate Scolnick, will host a conference call that same day at 4:30 p.m. ET to discuss these results and provide a business update.

Owlet, Inc. (“Owlet”) (NYSEOWLT) today announced that it will participate in the Cowen 43rd Annual Health Care Conference taking place on March 6-8, 2023 at the Boston Marriott Copley Place in Boston, Massachusetts. Kurt Workman, Owlet’s Co-Founder, President and Chief Executive Officer, and Kate Scolnick, Chief Financial Officer, are scheduled to present at the conference on Tuesday, March 7 at 1:30 p.m. EST. A link to the live webcast of the fireside chat will be available on the Owlet Investor Relations website, investors.owletcare.com. A replay of the webcast will also be available on Owlet’s Investor Relations website.

Owlet, Inc. (NYSEOWLT) (“Owlet” or the “Company”) today announced it has consummated a sale of its newly issued Series A convertible preferred stock (“Series A preferred stock”) and warrants to purchase its Class A common stock (“common stock”) in a private placement with certain institutional and other accredited investors for gross proceeds to Owlet of $30 million, before deducting offering expenses. The transaction closed on February 17, 2023 and involved participation from new and existing investors.

Owlet, Inc. (NYSEOWLT) (the “Company”) announces that the U.S. Food and Drug Administration (“FDA”) has accepted for substantive review the Company’s de novo classification request seeking clearance to expand the functionality of Owlet’s Dream Sock’s existing sleep monitoring capabilities to include opportunistic heart rate and oxygen notifications, through software as a medical device that Owlet calls “Health Notifications.” Designed for parents and caregivers to monitor healthy babies at home, the Health Notifications software would provide displays of live heart rate and oxygen saturation for babies, in addition to the opportunistic notifications when these readings move beyond certain ranges.

Owlet, Inc. (NYSEOWLT) (the “Company”) reports that on November 29, 2022, it received notice from the New York Stock Exchange (“NYSE”) that as of November 28, 2022, the average closing price of the Company’s common stock was less than $1.00 per share over a period of 30 consecutive trading days, and the Company is therefore not in compliance with Section 802.01C of the NYSE Listed Company Manual.

Owlet, Inc. (“Owlet”) (NYSEOWLT) today announced that it will participate in the BTIG Digital Health Forum on Monday, November 21, 2022. Kurt Workman, Owlet’s Co-Founder, President and Chief Executive Officer, and Kate Scolnick, Chief Financial Officer, are scheduled to present at the forum on November 21, 2022 at 1:30 p.m. EST. To view the live presentation, please contact BTIG by email at info@btig.com.

Owlet, Inc. ("Owlet" or the "Company") (NYSEOWLT) today reported financial results for the third quarter ended September 30, 2022. Owlet’s President and Chief Executive Officer, Kurt Workman, and Chief Financial Officer, Kate Scolnick, will host a conference call to review the Company’s results and provide a business update today, November 14, 2022 at 4:30 p.m. ET.

Owlet, Inc. (NYSEOWLT) will release its third quarter 2022 financial results after the market closes on November 14, 2022. Owlet will issue a copy of the earnings release via Business Wire and include a copy on Owlet’s Investor Relations website at investors.owletcare.com. Owlet’s President and Chief Executive Officer, Kurt Workman, and Chief Financial Officer, Kate Scolnick, will host a conference call that same day at 4:30 p.m. ET to discuss these results and provide a business update.

Owlet, Inc. (NYSE: OWLT, “Owlet” or “the Company”) today reports preliminary unaudited net revenue results for the fiscal quarter ended September 30, 2022. The Company estimates its net revenues for the third quarter of this year will be $16 million to $18 million.

Owlet, Inc. (NYSEOWLT) (the “Company”) announces that it has submitted a 510(k) premarket notification to the U.S. Food and Drug Administration (“FDA”) for a new prescription monitoring device for infants. The Company’s device, which uses pulse oximetry technology, is intended to be prescribed by physicians for assisting with the in-home monitoring of babies under a physician’s care. The device provides alerts to parents when their baby’s heart rate or oxygen saturation level (SpO2) does not fall within prescribed ranges.

Owlet, Inc. (“Owlet”) (NYSEOWLT) today announced that it will participate in the Citi 2022 Global Technology Conference, which takes place on Wednesday, September 7 through Friday, September 9, 2022 in New York City. Kurt Workman, Owlet’s Co-Founder, President and Chief Executive Officer, and Kate Scolnick, Chief Financial Officer, will participate in a fireside chat at the conference on September 9, 2022 at 9:45 a.m. EDT. A link to the live webcast of the fireside chat will be available on the Owlet Investor Relations website, investors.owletcare.com. A replay of the webcast will also be available on Owlet’s Investor Relations website.

Owlet, Inc. ("Owlet" or the "Company") (NYSEOWLT) today reported preliminary unaudited financial results for the second quarter ended June 30, 2022. Owlet’s Chief Executive Officer, Kurt Workman, and Chief Financial Officer, Kate Scolnick, will host a conference call to review the Company’s results and provide a business update today, August 11, 2022 at 4:30 p.m. ET.

Owlet, Inc. (NYSEOWLT) will release its second quarter 2022 results after the market closes on August 11, 2022. Owlet will issue a copy of the earnings release via Business Wire and include a copy on Owlet’s Investor Relations website at investors.owletcare.com. Owlet’s Chief Executive Officer, Kurt Workman, and Chief Financial Officer, Kate Scolnick, will host a conference call that same day at 4:30 p.m. ET to discuss these results and provide a business update.

This week, Owlet (NYSE: OWLT, “the Company”), the brand that has monitored more than one million babies, announced two new innovations to help parents, and their babies, get better sleep: Predictive Sleep Technology and the Owlet Cam 2. Predictive Sleep Technology is a completely automated sleep tool that tracks a baby’s sleep and wake windows using the Owlet Dream Sock, and provides recommendations via the Owlet Dream App on their next ideal sleep window. Owlet Cam 2 is the Company’s next-generation HD video monitor, bolstering the existing 1080p HD video with new artificial intelligence and machine learning to accurately decipher sounds from the nursery and detect when Baby is crying. Cam 2 also provides parents with video clips of sound and movement so they can better understand their little one, right from their phone.

Owlet, Inc. (NYSEOWLT) (“Owlet” or the “Company”) today announced that it will participate in the 7th Annual Cowen FutureHealth Conference, which takes place virtually on June 22-23, 2022. Kurt Workman, Owlet’s Co-Founder and Chief Executive Officer, and Kate Scolnick, Chief Financial Officer, will engage in a fireside chat at the conference on June 22, 2022, starting at 11:45 a.m. EDT.

Owlet, Inc. (NYSEOWLT) (“Owlet” or the “Company”) will join the Russell 3000® and Russell Microcap® Indexes later this month, at the conclusion of the 2022 Russell indexes annual reconstitution, according to the preliminary list posted by FTSE Russell on June 3, 2022. The reconstituted Russell indexes will be effective after the U.S. market opens on June 27, 2022.

Owlet, Inc. ("Owlet" or the "Company") (NYSEOWLT) today reported preliminary unaudited financial results for the first quarter ended March 31, 2022. Owlet’s Chief Executive Officer, Kurt Workman, and Chief Financial Officer, Kate Scolnick, will host a conference call to review the Company’s results today, May 11, 2022, at 4:30 p.m. ET.

Owlet, Inc. ("Owlet" or the "Company") (NYSEOWLT) today announced that it will participate in the Bank of America 2022 Global Healthcare Conference, which takes place May 9-13, 2022, in Las Vegas. Kurt Workman, Owlet’s Co-Founder and Chief Executive Officer, and Kate Scolnick, Chief Financial Officer, will present at the conference on May 12, 2022 at 10 a.m. PDT. A link to the live webcast of the presentation chat will be available on the Owlet Investor Relations website, investors.owletcare.com. A replay of the webcast will also be available on Owlet’s Investor Relations website.

Owlet, Inc. (NYSEOWLT) will release its first quarter 2022 results after the market closes on May 11, 2022. Owlet will issue a copy of the earnings release via Business Wire and include a copy on Owlet’s Investor Relations website at investors.owletcare.com. Owlet’s Chief Executive Officer, Kurt Workman, and Chief Financial Officer, Kate Scolnick, will host a conference call that same day at 4:30 p.m. ET to discuss these results and provide a business update.

Owlet, Inc. (NYSEOWLT), the brand that has monitored over 1 million babies, announces today new data on the state of sleep for parents, based on a national survey of 1,005 parents. The findings showcase the challenges and lack of sleep parents of children who are 12 months or younger experience.

Owlet, Inc. (NYSEOWLT) will report its results for the fourth quarter and full year, ended December 31, 2021 after market on March 7, 2022. Owlet’s Chief Executive Officer, Kurt Workman, and Chief Financial Officer, Kate Scolnick, will host a conference call to review these results and provide a business update beginning at 5:00 p.m. ET.

Today, Owlet, Inc. (NYSEOWLT) announces the Dream Duo’s recognition as the “The Best New Tech for Families” by PARENTS. From the brand that has monitored over 1 million babies, Owlet’s new smart baby monitor system tracks sleep and provides personalized insights about a baby’s sleep-related needs. The newest offering empowers parents to take an active role in their child’s sleep management and help build healthy sleep habits that last a lifetime.

Today, Owlet, Inc. (NYSEOWLT) launched the Owlet Dream Duo, its newest smart baby monitor system that tracks sleep and provides personalized insights about a baby’s sleep-related needs. Combining Owlet’s advanced technology and expert-led sleep program, the Dream Duo empowers parents to take an active role in their child’s sleep management and build healthy sleep habits that last a lifetime.

Owlet, Inc. ("Owlet" or the "Company") (NYSEOWLT) today reported financial results for the third quarter ended September 30, 2021. Owlet’s Chief Executive Officer, Kurt Workman, and Kate Scolnick, Chief Financial Officer, will host a conference call to review the Company’s results today at 4:30 pm EDT.

Owlet, Inc. (NYSEOWLT) will report its results for the third quarter ended September 30, 2021 after market on Wednesday, November 10, 2021. Owlet’s Chief Executive Officer, Kurt Workman, and Chief Financial Officer, Kate Scolnick, will host a conference call to review these results and provide a business update beginning at 4:30 p.m. ET.

Owlet, Inc. ("Owlet" or the "Company") (NYSEOWLT) today announced that it will participate in the Citi 2021 Global Technology Virtual Conference, which takes place September 13-15, 2021. Kurt Workman, Owlet’s Co-Founder and Chief Executive Officer, and Kate Scolnick, Chief Financial Officer, will engage in a fireside chat on September 15 at 9:40 a.m. EDT. A link to the live webcast of the chat will be available in the Investor Relations section of the Owlet website here. A replay of the webcast will be available for one year.

Owlet, Inc. (NYSEOWLT) will report its results for the second quarter ended June 30, 2021 after market on Thursday, August 12, 2021. Owlet’s Chief Executive Officer, Kurt Workman, and Kate Scolnick, Chief Financial Officer, will host a conference call to review these results and provide a business update in a conference call beginning at 4:30 p.m. ET.

Owlet, Inc. (NYSEOWLT) (“Owlet” or the “Company”), a company building a connected and accessible nursery ecosystem that brings technology and vital data to modern parenting, today announced that it has completed its business combination with Sandbridge Acquisition Corporation. NYSE: SBGNYSESBG)